DEUTSCHE BANK AG\ - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 83 filers reported holding ENZO BIOCHEM INC in Q1 2021. The put-call ratio across all filers is 4.25 and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q1 2021$99,000
+25.3%
28,840
-8.6%
0.00%
Q4 2020$79,000
+64.6%
31,538
+39.6%
0.00%
Q3 2020$48,000
+4.3%
22,596
+10.5%
0.00%
Q2 2020$46,000
+31.4%
20,448
+48.9%
0.00%
Q1 2020$35,000
-36.4%
13,731
-35.6%
0.00%
Q4 2019$55,000
+37.5%
21,329
+83.8%
0.00%
Q3 2019$40,000
-64.6%
11,606
-65.8%
0.00%
Q2 2019$113,000
-52.1%
33,891
-61.0%
0.00%
Q1 2019$236,000
-33.0%
86,991
-31.4%
0.00%
Q4 2018$352,000
-79.3%
126,813
-69.3%
0.00%
Q3 2018$1,698,000
-54.5%
412,558
-42.6%
0.00%
-100.0%
Q2 2018$3,729,000
+68.7%
718,838
+78.1%
0.00%0.0%
Q1 2018$2,211,000
+44.5%
403,698
+114.7%
0.00%0.0%
Q4 2017$1,530,000
+167.5%
187,994
+242.9%
0.00%
Q3 2017$572,000
-28.2%
54,818
-24.2%
0.00%
-100.0%
Q2 2017$797,000
+816.1%
72,347
+580.8%
0.00%
Q1 2017$87,000
-54.7%
10,627
-61.8%
0.00%
Q4 2016$192,000
-77.5%
27,818
-83.4%
0.00%
-100.0%
Q3 2016$852,000
-45.5%
167,634
-36.0%
0.00%0.0%
Q2 2016$1,563,000
+247.3%
262,020
+164.3%
0.00%
Q1 2016$450,000
+26.8%
99,153
+25.4%
0.00%
Q4 2015$355,000
+886.1%
79,092
+578.1%
0.00%
Q3 2015$36,000
-82.5%
11,664
-82.9%
0.00%
Q2 2015$206,000
+19.8%
68,292
+16.3%
0.00%
Q1 2015$172,000
+50.9%
58,722
+127.9%
0.00%
Q4 2014$114,000
+11300.0%
25,763
+7659.9%
0.00%
Q3 2014$1,000
-99.6%
332
-99.3%
0.00%
Q2 2014$242,000
+656.2%
46,311
+492.0%
0.00%
Q1 2014$32,0007,823
+55778.6%
0.00%
Q3 2013$0140.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q1 2021
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders